Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update
Go back to Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update| (NYSE: RCUS) | Delayed: 18.54 -0.82 (4.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.36 | 52 Week High | $ | |||
| Open | $19.02 | 52 Week Low | $ | |||
| Day High | $19.09 | P/E | N/A | |||
| Day Low | $18.43 | EPS | $ | |||
| Volume | 5,925,218 | |||||



